WallStSmart
EVGN

Evogene

NASDAQ: EVGN · HEALTHCARE · BIOTECHNOLOGY

$0.78
+2.88% today

Updated 2026-04-30

Market cap
$9.54M
P/E ratio
P/S ratio
2.48x
EPS (TTM)
$-1.70
Dividend yield
52W range
$1 – $2
Volume
0.1M

Evogene (EVGN) Financial statements

SEC filings — annual and quarterly data.

Balance sheet — annual

Item201020112012201320142015201620172018201920202021202220232024
Total assets$67.89M$67.89M$64.86M$137.31M$127.59M$112.59M$95.99M$77.60M$58.69M$71.36M$71.92M$76.30M$56.13M$51.10M$39.86M
Cash & equivalents$6.46M$24.26M$95.45M$5.21M$10.22M$3.24M$3.44M$5.81M$34.75M$46.23M$32.33M$28.98M$20.77M$15.30M
Current assets$57.32M$129.55M$118.37M$104.38M$89.49M$72.79M$55.49M$49.03M$51.82M$56.89M$37.75M$34.47M$21.59M
Total liabilities$19.80M$16.60M$12.56M$11.50M$8.84M$8.70M$8.22M$8.39M$11.15M$15.03M$12.88M$21.34M$22.42M$25.03M
Current liabilities$9.08M$9.50M$8.57M$7.92M$5.64M$5.22M$4.66M$5.43M$5.75M$9.68M$6.88M$5.63M$6.94M$18.70M
Long-term debt$10.11M$10.37M
Shareholder equity$48.09M$48.26M$124.75M$116.08M$103.75M$87.29M$69.38M$50.05M$50.14M$46.05M$53.65M$27.93M$12.05M$-1.45M
Retained earnings$-35.98M$-44.86M$-59.39M$-76.60M$-96.19M$-117.03M$-137.79M$-155.90M$-179.28M$-207.07M$-233.71M$-257.59M$-274.07M
Accounts receivable$1.72M$2.42M$1.86M$3.52M$1.18M$813000.00$746000.00$1.21M$2.17M$1.17M$803000.00$804000.00$1.49M
Inventory$-733000.00$-29.05M$-18.56M$-13.09M$-8.33M$-444000.00$-894000.00$-1.38M$92000.00$566000.00$76000.00$1.82M
Goodwill